12 assets in REM Sleep Behavior Disorder

Therapeutic assets addressing REM Sleep Behavior Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ioflupane REM Sleep Behavior Disorder	Weill Medical College of Cornell University	P4	BBB (72)
3-IODOBENZYLGUANIDINE (123I) REM Sleep Behavior Disorder	Mayo Clinic	P4	BB (65)
Rasagiline REM Sleep Behavior Disorder	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2/3	B (57)
Adalimumab REM Sleep Behavior Disorder	Yale University	P2	CCC (53)
Carvedilol REM Sleep Behavior Disorder	Cedars-Sinai Medical Center	P2	CCC (53)
Terazosin REM Sleep Behavior Disorder	Cedars-Sinai Medical Center	P2	CCC (53)
PE 2I REM Sleep Behavior Disorder	Universitaire Ziekenhuizen KU Leuven	P1/2	CCC (52)
Propofol REM Sleep Behavior Disorder	Nyree Penn	P1	CC (43)
Fludeoxyglucose REM Sleep Behavior Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
mk-6240 REM Sleep Behavior Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
SDM-8 REM Sleep Behavior Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)